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Abstract
Mitochondria play a critical role in bioenergetics, enabling stress adaptation, and therefore, are central in biological
stress responses and stress-related complex psychopathologies. To investigate the effect of mitochondrial dysfunction
on the stress response and the impact on various biological domains linked to the pathobiology of depression, a novel
mouse model was created. These mice harbor a gene trap in the first intron of the Ndufs4 gene (Ndufs4GT/GT mice),
encoding the NDUFS4 protein, a structural component of complex I (CI), the first enzyme of the mitochondrial
electron transport chain. We performed a comprehensive behavioral screening with a broad range of behavioral,
physiological, and endocrine markers, high-resolution ex vivo brain imaging, brain immunohistochemistry, and multi-
platform targeted mass spectrometry-based metabolomics. Ndufs4GT/GT mice presented with a 25% reduction of CI
activity in the hippocampus, resulting in a relatively mild phenotype of reduced body weight, increased physical
activity, decreased neurogenesis and neuroinflammation compared to WT littermates. Brain metabolite profiling
revealed characteristic biosignatures discriminating Ndufs4GT/GT from WT mice. Specifically, we observed a reversed
TCA cycle flux and rewiring of amino acid metabolism in the prefrontal cortex. Next, exposing mice to chronic variable
stress (a model for depression-like behavior), we found that Ndufs4GT/GT mice showed altered stress response and
coping strategies with a robust stress-associated reprogramming of amino acid metabolism. Our data suggest that
impaired mitochondrial CI function is a candidate driver for altered stress reactivity and stress-induced brain metabolic
reprogramming. These changes result in unique phenomic and metabolomic signatures distinguishing groups based
on their mitochondrial genotype.
Introduction
An adequate stress response comprises of various
simultaneous processes which are necessary to adapt to
the stressor appropriately1. All these processes combined
require significant resources, including energy in the form
of ATP, primarily synthesized by the mitochondria.
Besides energy production, mitochondria are known to
play a crucial role during the stress response2 and have
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even been shown to influence the stress adaptation
response3. Furthermore, severe stress can directly influ-
ence mitochondria, primarily in a negative manner4–7.
As stress is one of the most important risk factors in the
etiology of major depressive disorder (MDD)8–10, the
interaction between stress and the mitochondrial function
is intriguing. An increasing amount of evidence points
toward the involvement of the mitochondria in the
pathobiology of MDD2,11–13. Individuals with mitochon-
drial disease (MD; i.e., having severely impaired mito-
chondrial function) show a markedly higher prevalence of
MDD compared to the general population14,15. Similarly,
decreased mitochondrial function has been reported in
MDD patients11,12, as well as in animal models of
depression5–7.
Despite this accumulating evidence for mitochondrial
involvement in the etiology of stress-related depression,
in vivo modeling remains challenging. Animal models
with mitochondrial dysfunction often show severe phe-
notype and are lethal at an early age, making them
unsuitable for psychopathological research16. Here, we
generated a novel mouse model with suboptimal mito-
chondrial function, the Ndufs4GT/GT mice. These mice
have a relatively mild phenotype in comparison to most
known MD mouse models (for further details see results
section). We report on a broad range of behavioral, phy-
siological, and endocrine markers, as well as high-
resolution ex vivo brain imaging, brain immunohis-
tochemistry, and targeted mass spectrometry-based
metabolomics. We hypothesized that in Ndufs4GT/GT
mice, impaired mitochondrial complex I function, would
be a candidate driver event in elevated stress susceptibility
and that stress-induced brain metabolic reprogramming
would produce unique signatures that would discriminate
stress resilience versus susceptibility.
Materials and methods
Generation of the novel mouse model
Mutations in the NADH dehydrogenase [ubiquinone]
iron-sulfur protein 4 (Ndufs4) gene are associated with
complex I (CI) deficiency, the most common enzymatic
defect associated with oxidative phosphorylation dis-
orders17–20. NDUFS4 is an 18 kDa nuclear-encoded subunit
of mitochondrial CI, an essential part of the electron
transport chain (ETC)17,19,21. Complete ablation of Ndufs4
in mice results in a Leigh-like phenotype with multisystem
involvement21–24. Similarly to most animal models with
mitochondrial dysfunction16, Ndusf4 KO mice reach
humane endpoint before puberty (~7 weeks of age)22,
making it challenging to investigate the mitochondrial
etiology of affective disorders. Therefore, we sought to
create a novel mouse model with lower mitochondrial
function with a less severe phenotype. In order to do this, we
took advantage of a gene trap insertion in the first intron of
Ndufs425 to generate a novel mouse model of a partial
deficiency of the NDUFS4 protein. In short, a mouse ES cell
line (129Ola) with a gene trap insertion in intron 1 of
Ndufs4 (ES cell line CB0524) was obtained from the Inter-
national Gene Trap Consortium (through Sanger Institute
Gene Trap Resource or SIGTR26). The Ndufs4CB0524 cell
line was originally isolated from a large-scale gene trap
experiment where 129Ola ES cells were transfected with the
gene trap construct pGT0lxfT1 (25, https://igtc.org/). The
cell line was microinjected into C57BL/6 donor blastocysts
to generate transgenic line (performed by Genetically
Engineered Mouse Core at Baylor College of Medicine). The
mouse line used for this study was initially backcrossed for
20 generations onto the FVB/NJ inbred background. Mice
used for this study were generated by heterozygous
breeding.
Chronic unpredictable stress paradigm
Chronic unpredictable stress (CUS) has been used for
many years as a model for mood disorders, including
depression27,28. We subjected 10-week-old male mice
homozygous for the Ndufs4 gene trap (Ndufs4GT/GT) and
male WT mice to CUS for 21 days with one stressor or a
behavioral test each day (Fig. S1). Both WT and
Ndufs4GT/GT mice were allocated to either control or
stress groups in a semi-randomized manner. This was
done in a way that all groups presented similar body
weights at the start of the experiment. This resulted in a
total of four groups: WT control (n= 27), WT stress (n=
26), Ndufs4GT/GT control (n= 26), and Ndufs4GT/GT
stress (n= 30). The sample size used in this study was
estimated based on a power calculation following a pilot
study. Twenty-four hours after the last stressor, the ani-
mals were sacrificed by cervical dislocation without
anesthesia. During the stress paradigm, behavioral tests,
subsequent analysis of behavioral and biochemical tests,
the researchers were unaware of the mouse genotype and
experimental condition at all times. All animal experi-
ments were performed according to Dutch federal reg-
ulations for animal protection and were approved by the
Central Authority for Scientific Procedures on Animals
(CCD, AVD_103002016481; RU-DEC 2015-0117).
Approximately half of the animals were subjected to the
forced swim test (FST), Rotarod, open field, and splash
test while the other half of the animals were subjected to
the tail suspension test (TST), grip test, elevated plus
maze (EPM), and sucrose preference test (Fig. S1C). More
detailed descriptions of all experimental procedures,
including the housing of the animals, the CUS paradigm,
behavioral tests, mitochondrial complex measurements,
immunohistochemistry, MRI measurements, metabo-
lomics, and statistical methods are described in SI
Materials and Methods. Details on statistical outcomes
are provided in Supplementary Table 1. Based on our
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preestablished criterion, statistically significant outliers
were removed from all analysis.
Reagents
The following antibodies were used in this study: pri-
mary polyclonal goat anti-IBA-1 (Abcam, ab-5076),
polyclonal goat anti-DCX (C18) (Santa Cruz, sc-8066),
and polyclonal biotinylated donkey anti-goat secondary
antibody (Jackson ImmunoResearch, 705-065-003). Fur-
ther details on the immunohistochemical stainings can be
found in the SI Materials and Methods.
Statistics
For statistical analysis, IBM SPSS 24 software (IBM
Corporation, New York, NY, USA) was used. Five animals
were removed from all analyses. Two stressed Ndufs4GT/
GT mice showed stereotypical behavior, two WT animals
had a severely impaired mitochondrial CI activity whilst
one Ndufs4GT/GT animal had very high mitochondrial CI
activity. To determine differences between genotype (WT
or Ndufs4GT/GT) and condition (control or stressed), two-
way ANOVAs were used after testing for normality using
Shapiro–Wilk tests, as well as the Levene’s test for
equality of error variances. When a statistically significant
interaction was found between genotype and condition,
the ANOVA was rerun with simple effects using a Bon-
ferroni correction. When appropriate, repeated measures
ANOVAs were performed. When only the genotype was
assessed, Student’s t-tests were used to determine statis-
tical significance. Detailed outcomes of the statistical tests
and the sample sizes are summarized in Supplementary
Table 1. Statistical significance was set at P < 0.05,
whereas a statistical trend was set at P < 0.07. All data are
presented as mean ± SEM.
Results
Ndufs4-deficiency resulted in reduced mitochondrial
complex I activity
Ndufs4GT/GT mice exhibited a 50% reduction in both
Ndufs4 mRNA transcript, as well as NDUFS4 protein
abundance (Fig. 1a, b), resulting in a 25% reduction in CI
activity in the hippocampus compared to WT littermates
(Fig. 1c, Fig. S2). Mice heterozygous for the gene trap
showed CI activities comparable to WTs (Fig. S2A). The
activities of the other complexes of the mitochondrial
respiratory chain, maximal ATP production capacity, and
mitochondrial content (measured by citrate synthase (CS)
activity) were not affected (Fig. S2A-B). Despite several
studies showing that stress adversely affects mitochon-
drial function5,7, we found no effect of CUS on any of the
ETC complexes, maximal ATP production rate, or mito-
chondrial content (Fig. 1c, Fig. S2B).
Individuals with Ndufs4 mutations often present with
changes in brain structure21,24,29. We used high-
resolution ex vivo diffusion tensor imaging (DTI) to
study brain structure in 10-week-old Ndufs4GT/GT and
WT mice (Fig. 1i). We found no differences between
genotypes in various gray and white matter characteristics
analyzed (Fig. 1j, k, Fig. S3A-B).
Failure to thrive in Ndufs4GT/GT mice
Impaired mitochondrial function often involves multi-
ple organ systems in humans and mice, and include
symptoms such as growth retardation, failure to thrive,
and endocrine alterations21–24. We found that Ndufs4GT/
GT mice presented with failure to thrive; they were, on
average, 5% lighter than their WT littermates at 13 weeks
of age (Fig. 1d). Interestingly, this weight difference was
not apparent at weaning age, but developed slowly over
time with Ndufs4GT/GT mice gaining less body weight
each week (Fig. S4A). Animals exposed to CUS exhibited
lower body weight overall, irrespective of their genotype
(Fig. 1d) with an almost absent body weight increase
during CUS (Fig. 1e). Mice of both genotypes showed
comperable body weight change during CUS, as well as in
non-stressed conditions (Fig. S4B-C). As a clear sign of
chronic stress, adrenal weight was increased in both
genotypes (Fig. 1f).
Endocrine alterations in Ndufs4GT/GT mice
Corticosterone (CORT) is a central regulator of the
stress response. Comparing plasma concentrations of
CORT, we found that plasma CORT was lower under
baseline conditions in Ndufs4GT/GT mice (Fig. 1g). Indi-
viduals with MD often present with diabetes30,31, yet,
plasma glucose and insulin concentrations, as well as
insulin/glucose ratio, were comparable and within phy-
siological ranges in both genotypes (Fig. 1h, Fig. S5A-B),
suggesting that Ndufs4GT/GT mice do not present with a
diabetic phenotype. However, Ndufs4GT/GT mice exposed
to CUS exhibited altered CORT and glucose dynamics.
Following CUS, Ndufs4GT/GT mice had higher plasma
CORT levels, whereas WTs had lower levels compared to
their non-stressed counterparts (Fig. 1g). CUS further-
more negatively affected blood glucose levels in WT mice,
whereas glucose levels were not altered in Ndufs4GT/GT
mice (Fig. 1h). Despite this difference in glucose levels
following CUS, no difference in plasma insulin or insulin/
glucose ratio was observed (Fig. S5A-B).
Increased physical activity of Ndufs4GT/GT mice
MD often presents with fatigue and ataxia21–24, poten-
tially influencing the performance of Ndufs4GT/GT mice in
behavioral tests. Therefore, we assessed fatigue and grip
strength, motor coordination (Rotarod), and locomotion
(home cage activity, open field; Fig. S1C) for potential
confounding behaviors caused by the decreased complex I
activity in Ndufs4GT/GT mice. Under baseline conditions,
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Ndufs4GT/GT mice showed no evidence of fatigue or
muscle weakness in the Rotarod (Fig. 2a, b) and grip test
(Fig. 2c, d). In the Rotarod, all mice increased their per-
formance over time from trial 1 to trial 3 (Fig. 2b). Even in
tests where high physical activity is required, such as the
forced swim test (FST) and tail suspension test (TST),
Ndufs4GT/GT mice presented with no evidence of fatigue
either (Fig. 3a, d). Interestingly, Ndufs4GT/GT mice instead
displayed increased physical activity in several tests when
compared to WTs (Figs. 2a, f, 3a, d). Ndufs4GT/GT mice
Fig. 1 Physiological characterization of Ndufs4GT/GT mice. a Relative Ndufs4 mRNA expression normalized to B2m and Gapdh using the Pfaffl
method in the brain of WT (orange bars) and Ndufs4GT/GT (blue bars) mice. b NDUFS4 protein abundance relative to beta-Actin in the brain. c Z-scores
of mitochondrial complex I (CI) activity from hippocampal tissue. d Body weight as measured after 20 days of chronic unpredictable stress (CUS).
e Body weight change from the start of chronic stress to the end of the experiment. In this graph, the genotype is not shown since there was no
difference in body weight change between WT and Ndufs4GT/GT mice over time. f Adrenal weight expressed as a percentage of the body weight of
the animals. g Plasma corticosterone (CORT) levels measured one day after the last stressor. h Blood glucose concentrations measured with a
FreeStyle Freedom Lite glucose meter using a drop of trunk blood shortly after decapitation. i Representative images from one animal showing the
fractional anisotropy (FA) and mean diffusivity (MD) at different Bregmata. Approximately at Bregma 1.10 mm, 0.62 mm, −0.70 mm, −1.70 mm,
−2.80 mm, and −6.24 mm. j FA was measured in several different brain regions. k In these same regions, MD was also measured. Graphs show the
geometric mean (a) or average (b–h, j, k) ± SEM, with each black dot representing the result of an individual animal. *p < 0.05, **p < 0.01, and
***p < 0.001. Abbreviations: CC, corpus callosum; CP, cerebral peduncle; IC, internal capsule; AC, anterior commissure; CPu, caudate putamen; dHip,
dorsal part of the hippocampus; vHip, ventral part of the hippocampus; Mid, midbrain; CTX, cortex; Sub, subthalamic regions; Cereb, cerebellum.
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also showed increased home cage dark phase activity
under basal conditions (Fig. S6A). Following CUS, we
found a similar pattern of increased physical activity of
Ndufs4GT/GT mice in the open field, FST, and TST
(Figs. 2f, 3a, d). Their home cage activity showed the same
pattern of increased activity following CUS; however, this
did not reach statistical significance (Fig. S6B). This
increased activity of Ndufs4GT/GT mice could point to
increased restlessness, a symptom often seen in indivi-
duals with MD.
Stressed mice showed more anxiety-like behavior
Anxiety and depression are often observed as comorbid
disorders32, and anxiety is also increasingly associated
with mitochondrial dysfunction33–35. We measured
anxiety-like behavior using the open field test or elevated
plus maze (EPM, Fig. 2e, S7A, S8). Despite the increased
locomotion of Ndufs4GT/GT mice (see earlier), the time
spent in the center of the open field was not different
between genotypes at baseline (Fig. 2g). In the EPM, we
found no difference in exploration of the apparatus (Fig.
S7B-D). These data indicate that Ndufs4GT/GT mice do
not exhibit trait anxiety.
Following CUS, results from the open field suggest that
animals showed more anxiety-like behavior irrespective of
their genotype as stressed mice spent less time in the
center of the open field (Fig. 2g). Furthermore, stress
significantly increased emotional reactivity in the mice, as
indicated by increased defecation during the open field
test (Fig. 2h). Ndufs4GT/GT mice exposed to CUS showed
even higher emotional reactivity as they defecated more
than stressed WT mice (Fig. 2h). EPM revealed no
anxiety-like behavior in either genotype following CUS.
Stressed mice did not show increased locomotion, nor a
different exploration pattern of the EPM compared to
non-stressed mice (Fig. S7B-D).
Ndufs4GT/GT mice showed different stress coping styles
To assess affective behavior in mice, we utilized the
forced swim test (FST) and tail suspension test (TST). As
previously mentioned, Ndufs4GT/GT mice showed a more
active coping strategy in the FST and TST (Fig. 3a, b, d).
Interestingly, Ndufs4GT/GT mice displayed less climbing
behavior in the FST compared to WT mice (Fig. 3c).
Chronic stress did not influence the floating or swimming
behavior of either genotype in the FST (Fig. 3a, b).
Fig. 2 Lower mitochondrial complex I function in Ndufs4GT/GT mice did not negatively impact locomotor function or grip strength, but
Ndufs4GT/GT mice showed slightly more anxiety-related behavior following stress. a Average latency to fall from a rotating rod accelerating
from 4 to 40 rpm in 300s. b Average latency to fall from the rod during the three individual trials investigating the ability of the mice to adapt to the
test. c The average grip strength of the animals was measured using only their forepaws or (d) all four paws. The grip strength test measured the
peak force (in gram force, gf) of each animal. e Representative locomotion tracks from the open field with the center area delineated. Animals freely
explored the open field for 10 min. Traces of all animals during the open field are shown in Fig. S8. f The total distance moved in meters, (g) average
time spent in the center, and (h) defecation during the 10min in the open field were measured. Graphs show average ±SEM, with each black dot
representing the result of an individual animal. *p < 0.05, **p < 0.01, and ***p < 0.001, and #p < 0.07.
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Fig. 3 Ndufs4GT/GT animals showed a more active coping style in the forced swim test (FST) and tail suspension test (TST), they also had
less neurogenesis and inflammation in the brain. a The time the animals spent floating, (b) swimming, and (c) climbing was analyzed during the
last 4 min of the FST. Floating was defined as minimal movement of one hind paw so the animal could stay above the water without the animal
having a clear swimming direction. d During the TST, the total immobility time was measured. e During the sucrose preference test, mice could
choose between two bottles, one bottle containing 1% sucrose and one bottle containing tap water. Their sucrose preference was measured as a
percentage of total fluid intake. The dotted line indicates 65%, which has been suggested to be the threshold for anhedonia. f Total sucrose
consumption was also measured. The total sucrose consumption was normalized with the body weight of each animal. g After spraying the dorsal
coat of the animals with a 10% sucrose solution, the total time spent grooming and (h) average grooming ritual duration was measured. Grooming
ritual was defined as the time spent grooming divided by the frequency to start grooming. i The number of doublecortin (DCX) positive neurons was
counted as a marker for neurogenesis in the subgranular zone of the dentate gyrus (DG). j The number of DCX-positive neurons in the subventricular
zone (SVZ) was also measured. k Representative image from the DCX staining showing the hippocampus with DG and SVZ (arrows). The blue
rectangle represents an enlargement from the overview detailing DCX-positive cells in the DG. l As a proxy for inflammation in the brain, the number
of Ionized calcium-binding adapter molecule 1 (IBA-1) positive microglia were analyzed in the hippocampus. The number of positive cells was
normalized to the surface of the measured area. m Representative image from the IBA-1 staining. The number of IBA-1 cells was only counted in the
hippocampus and was corrected for the hippocampal surface, as indicated by the dashed blue line. The blue rectangle represents an enlargement
from the overview detailing several IBA-1 positive cells. Scale bars indicate 200 µm. Graphs show average ± SEM, with each black dot representing the
result of an individual animal. *p < 0.05, **p < 0.01, ***p < 0.001, and #p < 0.07.
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Climbing, the most energy demanding behavior in the
FST, however, was influenced by CUS. Ndufs4GT/GT mice
displayed drastically reduced climbing behavior following
CUS while climbing behavior in WT mice was not altered
(Fig. 3c). In the TST, chronic stress did not influence
behavior (Fig. 3d). Results from the FST indicate a specific
coping strategy of Ndufs4GT/GT mice; i.e., they exhibit an
active, but energy-saving coping behavior.
Ndufs4GT/GT mice consumed more sucrose
Anhedonia is one of the core symptoms of depression.
In animal models, anhedonia is assessed by the sucrose
preference test27,36. We found no difference in sucrose
preference between genotypes either under baseline
conditions or following CUS (Fig. 3e). However, when
calculating the amount of sucrose each animal consumes,
Ndufs4GT/GT mice consumed more sucrose (Fig. 3f).
Another symptom often observed in depression is self-
neglect. This symptom can be measured using the splash
test, a test to measure motivational and self-care behavior
in mice. Chronic stress is often shown to decrease
grooming behavior in mice37,38. In contrast to these stu-
dies, we found no difference in time spent grooming or
duration of the grooming ritual between WT and
Ndufs4GT/GT mice (Fig. 3g–h). Also, total grooming time
did not differ in either genotype following chronic stress
exposure. However, the average length of a grooming
ritual increased significantly in both genotypes following
chronic stress (Fig. 3h).
Ndufs4GT/GT mice had lower neurogenesis and brain
inflammation
Chronic stress is often associated with decreased adult
neurogenesis39, and optimal mitochondrial function is
necessary for adult hippocampal neurogenesis40. We
analyzed neurogenesis in the dentate gyrus (DG) of the
hippocampus and the subventricular zone (SVZ); two
brain areas where adult neurogenesis is confirmed and
often studied41,42. We used doublecortin (DCX) as a
proxy to study neurogenesis (Fig. 3k). Under baseline
conditions, Ndufs4GT/GT mice showed impaired/
decreased neurogenesis in both the DG and SVZ (Fig. 3i,
j). Following chronic stress, WT mice exhibited decreased
neurogenesis in both regions (Fig. 3i, j). However,
Ndufs4GT/GT mice did not show a further decrease in
newly formed neurons (Fig. 3i, j). These results suggest
that although adult neurogenesis is impaired in Ndufs4GT/
GT mice under baseline conditions, chronic stress did not
further exacerbate this phenotype.
Depression is also associated with increased levels of
inflammatory markers in humans43 and animals44. We
quantified the number of ionized calcium-binding adapter
molecule 1 (IBA-1) positive microglia in the hippocampus
(Fig. 3m), a frequently used marker for inflammation in
the brain. We found that Ndufs4GT/GT mice had fewer
IBA-1 positive microglia in the hippocampus (Fig. 3l). We
did not find any change in the number of IBA-1 positive
cells following CUS in either WT or Ndufs4GT/GT mice
(Fig. 3l).
Decreased mitochondrial function and chronic stress
resulted in metabolic rewiring
Considering the scope of metabolic perturbations in
MD45–48 and during chronic stress49,50, we performed
multi-platform targeted metabolomics from the pre-
frontal cortex focusing on amino acids (AA) and their
metabolites, acyl-carnitines (AC), as well as tricarboxylic
acid cycle (TCA) analytes. For a complete list of all
measured metabolites, see the SI materials and methods.
Amino acid metabolites
In preclinical studies, chronic stress-induced depression is
often accompanied by abnormal AA metabolism50,51.
Similarly, perturbations of the mitochondrial respiratory
chain have also been linked to altered AA metabolism45–48.
We found alterations of several AA metabolites in either
Ndufs4GT/GT or stressed mice (Fig. 4a, Fig. S9). Specifically,
Ndufs4GT/GT mice displayed elevated alanine concentrations
in the brain. Increased alanine is often used as a clinical
biomarker of mitochondrial dysfunction52. Besides alanine,
concentrations of glutamate, hydroxyproline, and serine
were increased in Ndufs4GT/GT mice, whereas concentra-
tions of arginine, beta-alanine, carnosine, cystathionine,
ethanolamine, gamma-aminobutyric acid (GABA), iso-
leucine, leucine, histidine, phenylalanine, proline, and tryp-
tophan were decreased (Fig. 4a, c, h, Fig. S9). CUS further
exacerbated several of these changes; specifically, we
observed a robust increase in alanine, hydroxyproline, lysine,
serine, and threonine irrespective of the genotype (Fig. 4c).
Given the robust rewiring of AA metabolism in both
naïve and chronically stressed Ndufs4GT/GT mice, we next
investigated whether a characteristic biosignature of AA
metabolites could discriminate between experimental
groups. A stepwise linear discriminant analysis (LDA)
revealed that cystathionine, phenylalanine, and serine
discriminated between Ndufs4GT/GT and WT mice
(Fig. 4b–f), whereas serine and threonine discriminated
between stressed and non-stressed mice (Fig. 4b, f, g).
The balance between excitatory and inhibitory neuro-
transmission is essential for normal brain function, and
deficits in both glutamate and GABA signaling have been
observed in mood disorders53–55. We found increased
glutamate and decreased GABA concentrations in the
prefrontal cortex of Ndufs4GT/GT mice (Fig. 4i, j). Con-
sequently, the GABA to glutamate ratio was also altered
(Fig. 4k), indicating a disturbed balance between inhibi-
tory and excitatory amino acids in the prefrontal cortex.
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Acyl-carnitine metabolites
Altered acyl-carnitines in plasma have been observed
in depressed subjects56, as well as in individuals with
MD46. We found that stress negatively influenced
medium-chain acylcarnitines (C8) in both WT and
Ndufs4GT/GT mice (Fig. S10). There was a similar trend
for C12 and C14; however, these did not reach statistical
significance. Overall, lower CI activity in Ndufs4GT/GT
mice did not significantly influence acyl-carnitine meta-
bolism (Fig. S10).
Fig. 4 Ndufs4GT/GT mice and chronically stressed mice show an altered metabolic rewiring. a Hierarchical clustering heat map of normalized (z-
score) levels for all measured amino acid (AA) metabolites. The dendrogram indicates the degree of correlation between each of the metabolites
across all four groups. b Stepwise linear discriminant analysis of all AA metabolites indicated that the AA profile discriminated the Ndufs4GT/GT mice
from WTs, as well as control from stress mice. c A highlight of the AA metabolites that were found to be statistically different between genotypes
(top) or chronic stress condition (bottom). Arrows indicate the direction of the change compared to WT and control. d–g The four metabolites
selected by the stepwise analysis as major contributing factors discrimination in the LDA analysis; cystathionine, phenylalanine, serine, and threonine,
respectively. h Relative tryptophan, (i) glutamate, and (j) gamma-aminobutyric acid (GABA) levels across all four groups. k Relative GABA to glutamate
ratio. Data were normalized to total AA concentration and show average ±SEM, with each black dot representing the result of an individual animal.
*p < 0.05, **p < 0.01, and ***p < 0.001.
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TCA cycle metabolites
Besides alterations in AA metabolism, individuals with
MD and in vivo models also show alterations in TCA
cycle metabolism46,47. We also identified disruptions in
TCA cycle metabolism in Ndufs4GT/GT mice (Fig. 5a–d).
More specifically, we found that Ndufs4GT/GT mice had a
lower concentration of citrate (Fig. 5b), cis-aconitate, and
isocitrate (Fig. S11). The combination of decreased citrate
and isocitrate, the unaltered abundance of α-ketogluta-
rate, but the decreased ratio of citrate to malate (Fig. 5c)
could be indicative of reverse flux in the TCA cycle in
Ndufs4GT/GT mice. Besides these genotypic alterations,
chronic stress did not influence TCA metabolism (Fig. 5d,
Fig. S11).
Discussion
To test the hypothesis that suboptimal mitochondrial
function increases susceptibility to stress-related psycho-
pathologies, such as depression, we used a novel mouse
model with a partial deficiency of mitochondrial complex I
function due to lower NDUFS4 protein abundance
(Ndufs4GT/GT mice). In contrast to the severe phenotype of
the Ndufs4 KOmouse22, Ndufs4GT/GT mice only presented
with a mild phenotype of failure to thrive, hyperactivity,
and increased sucrose consumption. In addition to this, we
found that Ndufs4GT/GT mice had altered plasma CORT
and glucose dynamics, as well as lower adult neurogenesis
and brain inflammation. Despite the lower adult neuro-
genesis, we found no changes in the brain structure of
Ndufs4GT/GT mice using ex vivo high-resolution DTI.
These findings indicate that a 25%-30% decrease in CI
activity is not sufficient to cause comparable (severe)
physiological, endocrine, and behavioral symptoms to
those seen in Ndufs4 KO mice between 5 and 7 weeks of
age and individuals with Leigh syndrome22,29.
We found no effect of the decreased CI activity on the
maximal ATP production rate in the hippocampus.
Although this might be surprising, it is in line with the
prediction by Alam, et al.57 suggesting that mouse skeletal
muscle mitochondria possess a substantial CI over-
capacity, which minimizes the effects of CI dysfunction on
mitochondrial metabolism. In one of their computational
models, they predicted that cellular ATP levels would only
drop after a 90% reduction in CI activity57. Similar lack of
change in cellular ATP level has been shown in other
animal and cellular Ndufs4 models, which show no, or
only marginally decreased ATP production while CI
activity is severely decreased22,57–60. In addition, there
may be several other compensatory mechanisms to
maintain cellular ATP levels upon decreased CI activity,
such as increased activities of other ETC complexes, or
increased TCA cycle activity22,57.
Taken together, the fact that Ndufs4GT/GT mice only
exhibit a mild phenotype under basal unstressed condi-
tions makes them a valuable animal model for studying
complex disorders associated with suboptimal mito-
chondrial function2,61 that require behavioral assess-
ments, albeit less suitable for studying mitochondrial
disease due to complex I dysfunction (Leigh syndrome).
To investigate the involvement of mitochondrial func-
tion in complex stress-associated disorders such as
depression and anxiety, we subjected Ndufs4GT/GT mice
to a chronic unpredictable stress (CUS) paradigm; a
model frequently used to induce depression/anxiety-like
phenotype in rodents28. We observed that the CUS
paradigm was successful in causing significant distress in
Fig. 5 Ndufs4GT/GT mice show signs of a reverse flux in the tricarboxylic acid (TCA) cycle. a Hierarchical clustering heat map of normalized
(z-score) levels for all measured TCA cycle metabolites. The dendrogram indicates the degree of correlation between each of the metabolites across
all four groups. b Relative citrate levels measured from the prefrontal cortex. c Relative citrate to malate ratio. d A highlight of the TCA metabolites
that were found to be statistically different between genotypes (top) or chronic stress condition (bottom). Data were normalized to total TCA
concentration and show average ± SEM, with each black dot representing the result of an individual animal. Asterisk (*) indicates p < 0.05.
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both WT and Ndufs4GT/GT mice, as indicated by an
attenuated body weight gain, an increased relative adrenal
weight, and increased open field locomotion. In addition
to these findings, Ndufs4GT/GT mice presented with
altered CORT and glucose dynamics following stress,
potentially making them more vulnerable to stress-
associated disorders, such as diabetes. This altered
CORT response following CUS is in line with a previous
study showing distinct CORT responses in various animal
models with different mitochondrial dysfunctions after
acute restraint stress3.
We could not, however, replicate findings that stress
directly influenced mitochondrial function4–7. One pos-
sibility may be the time point chosen to analyze stress-
induced changes in mitochondrial markers; i.e., all mice in
our study were sacrificed 24 h after the last stressor,
whereas in studies where stress-related mitochondrial
dysfunction has been reported, mice were sacrificed
immediately after the last stressor or did not specify the
timeframe4–7. Another possibility for this may be the fact
that we measured ETC complex activities in the hippo-
campus. We chose the hippocampus to measure ETC
complex activities because it has been implicated in the
etiology of depression62. However, based on our relatively
large set of unpublished data on ETC complex activities in
the hippocampus, and the fact that changes in mito-
chondrial function have been limited to the cortex and
cerebellum5–7, a picture is emerging that the hippo-
campus seems rather resilient to mitochondrial dysfunc-
tion. Clinical imaging data from individuals with MD also
supports this: gray matter lesions are often found in the
cortex, thalamus, brainstem, and basal ganglia21,24,29 while
the hippocampus seems to be preserved (personal com-
munication to Amy Goldstein, Center for Mitochondrial
Medicine, CHOP Philadelphia).
Besides these physiological differences following stress,
we also demonstrated that Ndufs4GT/GT mice presented
with altered stress coping strategies in the FST. Specifi-
cally, Ndufs4GT/GT mice prefer an active but less energy-
consuming coping strategy. This difference from WT
mice was already apparent at baseline but was further
exacerbated by chronic stress. Ndufs4GT/GT mice showed
a similar coping strategy in the TST too. Furthermore, we
found that Ndufs4GT/GT mice presented with increased
emotionality following CUS as indicated by the increased
defecation in the open field63–65
Depression has frequently been associated with
decreased neurogenesis39. In support of this, we also found
reduced neurogenesis in WT mice exposed to CUS. In
agreement with earlier studies40,66, we also demonstrated
that suboptimal mitochondrial function negatively influ-
ences neurogenesis in Ndufs4GT/GT mice. The decreased
neurogenesis in Ndufs4GT/GT mice at baseline could be
mediated by the decreased number of microglia we found
in the brain, as they also play a positive role during adult
neurogenesis67. This difference in baseline neurogenesis
could make Ndufs4GT/GT mice more vulnerable to stress as
it has been shown that ablation of neurogenesis can
enhance stress susceptibility68. The combination of
chronic stress and decreased mitochondrial function did
not further impair neurogenesis, probably because of a
potential floor-effect as a result of the already low number
of newly made neurons in Ndufs4GT/GT mice.
Taken together, Ndufs4GT/GT mice seem to recapitulate
several phenotypes of the High Reactivity (HR) mice; a
mouse model postulated to model the melancholic
depressive behavior69. Similar to HR mice, our Ndufs4GT/GT
mice show hyperactivity and hyperactive coping strategies
in most behavioral tests, decreased body weight, decreased
neurogenesis, and altered CORT reactivity.
Using multi-platform targeted metabolomics, we also
found abnormal amino acid metabolism, an indication
towards a reverse flux in the TCA cycle, but no specific
perturbation in acyl-carnitine metabolites following
chronic stress. The profound alterations in AA bio-
signatures in both control and stressed Ndufs4GT/GT mice
point to a metabolic rewiring, as defined by the change in
mitochondrial activity and subsequent alteration/redis-
tribution of intracellular energy flow and metabolism,
driven by altered brain energy metabolism. These bio-
signatures largely overlap with previous clinical and pre-
clinical studies of mitochondrial dysfunction45–47,
indicating that alterations in AA metabolites could be a
characteristic biosignature for altered energy flow in the
brain. If one focusses on specific AA metabolites, the
elevation in alanine concentration in Ndufs4GT/GT mice is
particularly noteworthy. Alanine is often elevated in
clinical and preclinical models of MD and therefore
considered a biomarker for MD45.
Four amino acids—cystathionine, phenylalanine, serine,
and threonine—were identified by a stepwise LDA to be
able to discriminate between genotypes and stress con-
ditions. Serine and cystathionine have frequently been
found to be elevated in MD patients70–73. In agreement
with previous studies, we found elevated serine in
Ndufs4GT/GT mice; however, cystathionine was decreased
in the brains of Ndufs4GT/GT mice. This latter finding is
unusual since most studies show an elevated cystathionine
in MD70–73. This discrepancy could be because we mea-
sured the amino acids in the brain, whereas other studies
usually assay other tissues or plasma. Also, within the
brain, different regions may show different amino acid
alterations following stress exposure74,75. Taken together,
these findings indicate alterations in the one-carbon
metabolism in Ndufs4GT/GT mice, probably supporting
increased glutathione synthesis, a potent antioxidant76.
Besides the parallel alterations in AA metabolites in our
animal model and previously published literature, we also
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identified distinct changes in AA metabolites. These could
point to (1) particular biosignatures for a specific clinical
or preclinical model of mitochondrial dysfunction;45,48 (2)
biosignatures that differentiate based on the severity of
mitochondrial dysfunction77; (3) specific alterations for
the brain region we analyzed.
Several studies demonstrate that chronic stress exposure,
depression, and anxiety cause alterations in both excitatory
glutamate, as well as inhibitory GABA neurotransmis-
sion54,74,75. Similar to these studies, we observed increased
glutamate and decreased GABA levels in the PFC of
Ndufs4GT/GT mice, resulting in an altered balance between
these inhibitory and excitatory neurotransmitters. Several
human studies reported lower mPFC GABA levels in
MDD, and reduced mPFC GABA levels have been asso-
ciated with treatment resistance78. These findings suggest
that GABA may play a crucial role in multiple pathways
leading to mPFC structural deficits in depression54,78. In
addition, our finding of increased emotional reactivity of
Ndufs4GT/GT mice is in line with a recent review suggesting
that mitochondria could contribute to anxiety through
alterations in the GABA/glutamate ratio79.
Another neurotransmitter of interest could be ser-
otoninergic neurotransmission. Although we did not
measure serotonin levels directly, we found decreased
levels of tryptophan in Ndufs4GT/GT mice. Tryptophan
metabolism is essential in the synthesis of serotonin since
tryptophan is the sole precursor for serotonin. This
finding is in line with previous studies that observed
decreased tryptophan levels in depressed patients80,81. In
turn, this could indicate a shunted metabolism of tryp-
tophan away from serotonin production and increased
synthesis of detrimental tryptophan catabolites80,82,83.
The results of this study have to be considered with
some limitations. First, the Ndufs4GT/GT mice analyzed
here were in an FVB background. This could attribute to
the lack of classical behavioral changes following CUS in
both WT and Ndufs4GT/GT mice, despite the several
physiological, biochemical, and histological changes found
in this study. It is not uncommon for FVB mice to show
behavioral resilience following chronic stress84, and FVB
mice usually show low inactive behaviors in the FST and
TST85,86. Apparently, the physiological, biochemical, and
histological changes induced by stress do not correlate to
the behavior in this mouse strain following chronic stress.
Second, mice with the FVB background harbor a muta-
tion in the ATP8 mtDNA gene87. Mutations in this gene
have been, in addition to the ATP6 gene, implicated in
individuals with a family history of psychiatric disorders88.
Therefore, when comparing data from FVB mice (this
study) and those of the literature, which mostly investi-
gate C57BL/6J mice, a potential strain difference has to be
taken into consideration. Future studies are warranted to
address this potential limitation. Third, all mice had to be
individually housed, as individual housing is recom-
mended by the Institute for Laboratory Animal Research
for FVB mice89 due to the highly aggressive nature of this
strain, even towards littermates90,91.
We conclude that stress-induced behavioral, endocrine,
metabolic, and physiological responses merged into
unique signatures that distinguished groups based on
their mitochondrial genotype. In addition, we confirmed a
link between impaired brain energy metabolism and
altered biological stress response of increased emotion-
ality, hyperactivity and hyperactive coping strategies,
decreased body weight and neurogenesis, as well as
altered CORT reactivity resembling a melancholic
depression phenome. Upon interpretation of these results,
one should, however, consider that the biological stress
response, as well as the regulation of mood, are comprised
of multiple endocrine, physiological, and behavioral
domains. Thus, this novel Ndufs4GT/GT mouse could be a
valuable in vivo model system to study specific biological
domains/endophenotypes of depression and anxiety that
could be more vulnerable to impaired brain bioenergetics.
Our model could also serve as a platform for identifying
novel therapeutic avenues for complex psychopathologies
associated with suboptimal mitochondrial function.
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